Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Zecca

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2022
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YESChiara Zecca, Claudio Gobbi
CNS & Neurological Disorders Drug Targets|August 16, 2011
Chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS): a critical reviewChiara Zecca, Claudio Gobbi
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2010
Hydrocephalus during natalizumab treatmentChiara Zecca, Claudio Städler, Claudio Gobbi
Patient Preference and Adherence|August 29, 2012
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patientsChiara Zecca, Nikhil Yawalkar, Claudio Gobbi
Neurology|September 25, 2009
Ocular toxoplasmosis during natalizumab treatmentChiara Zecca, Fabio Nessi, Enos Bernasconi, et al.
Neurology|October 17, 2022
Reader Response: Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic StudyDavide Sparasci, Chiara Zecca, Claudio Gobbi, et al.
BMC Neurology|September 6, 2017
Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE studyChiara Zecca, Giulio Disanto, Sarah Mühl, et al.
CNS & Neurological Disorders Drug Targets|December 19, 2012
Restless legs syndrome in multiple sclerosisChiara Zecca, Mauro Manconi, Stephany Fulda, et al.
Patient Preference and Adherence|July 24, 2014
Life-threatening asthma attack during prolonged fingolimod treatment: case reportChiara Zecca, Matteo Caporro, Sandor Györik, et al.
BMC Neurology|December 4, 2015
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection--a case reportChiara Zecca, Carlo Mainetti, Roland Blum, et al.
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 12, 2022
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YESChiara Zecca, Claudio Gobbi
CNS & Neurological Disorders Drug Targets|August 16, 2011
Chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis (MS): a critical reviewChiara Zecca, Claudio Gobbi
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2010
Hydrocephalus during natalizumab treatmentChiara Zecca, Claudio Städler, Claudio Gobbi
Patient Preference and Adherence|August 29, 2012
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patientsChiara Zecca, Nikhil Yawalkar, Claudio Gobbi
Neurology|September 25, 2009
Ocular toxoplasmosis during natalizumab treatmentChiara Zecca, Fabio Nessi, Enos Bernasconi, et al.
Neurology|October 17, 2022
Reader Response: Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic StudyDavide Sparasci, Chiara Zecca, Claudio Gobbi, et al.
BMC Neurology|September 6, 2017
Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE studyChiara Zecca, Giulio Disanto, Sarah Mühl, et al.
CNS & Neurological Disorders Drug Targets|December 19, 2012
Restless legs syndrome in multiple sclerosisChiara Zecca, Mauro Manconi, Stephany Fulda, et al.
Patient Preference and Adherence|July 24, 2014
Life-threatening asthma attack during prolonged fingolimod treatment: case reportChiara Zecca, Matteo Caporro, Sandor Györik, et al.
BMC Neurology|December 4, 2015
Recurrent Nicolau syndrome associated with subcutaneous glatiramer acetate injection--a case reportChiara Zecca, Carlo Mainetti, Roland Blum, et al.
Pageof 22